|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|
| Current assets: | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Total current assets | ||||
| Deferred offering costs | ||||
| Cash and investments held in trust account | ||||
| Total Assets | ||||
| Current liabilities: | ||||
| Accrued expenses | ||||
| Promissory note – related party | ||||
| Accounts payable and accrued expenses | ||||
| Total current liabilities | ||||
| Deferred underwriting commissions | ||||
| Total liabilities | ||||
| Class A ordinary shares, $0.0001 par value; 23,000,000 shares subject to possible redemption at $10.27 and $10.06 per share as of June 30, 2025 and December 31, 2024, respectively | ||||
| Shareholders’ Deficit | ||||
| Ordinary shares, value | ||||
| Class A Ordinary Shares | ||||
| Class B Ordinary Shares | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Shareholders’ Deficit | ||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...
